Silesian University of Technology, Department of Organic Chemistry, Bioorganic Chemistry and Biotechnology, Krzywoustego 4, 44-100 Gliwice, Poland, Tel.: +48 32 237 1792.
Beilstein J Org Chem. 2011 Feb 8;7:173-8. doi: 10.3762/bjoc.7.24.
An optimisation of Michael-type addition of azole derivatives of broad-scale acidity - ranging from 5.20 to 15.00 pK(a) units - namely 4-nitropyrazole, 3,5-dimethyl-4-nitropyrazole, 4(5)-nitroimidazole, 4,5-diphenylimidazole, 4,5-dicyanoimidazole, 2-methyl-4(5)-nitroimidazole, 5(4)-bromo-2-methyl-4(5)-nitroimidazole and 3-nitro-1,2,4-triazole to methyl acrylate as an acceptor was carried out. The optimisation process involved the use of an appropriate basic catalyst (DBU, DIPEA, NaOH, NaH, TEDA), a donor/base/acceptor ratio and the reaction temperature. The reactions were performed in DMF as solvent. Target Michael adducts were obtained in medium to excellent yields. Importantly, for imidazole and 1,2,4-triazole derivatives, no corresponding regioisomers were obtained.
对具有较宽酸度范围(pKa 值为 5.20 至 15.00)的唑类衍生物(如 4-硝基吡唑、3,5-二甲基-4-硝基吡唑、4(5)-硝基咪唑、4,5-二苯基咪唑、4,5-二氰基咪唑、2-甲基-4(5)-硝基咪唑、5(4)-溴-2-甲基-4(5)-硝基咪唑和 3-硝基-1,2,4-三唑)与甲基丙烯酸酯的迈克尔加成反应进行了优化。优化过程涉及使用合适的碱性催化剂(DBU、DIPEA、NaOH、NaH、TEDA)、供体/碱/受体比例和反应温度。反应在 DMF 溶剂中进行。以中等至优异的产率获得了目标迈克尔加成产物。重要的是,对于咪唑和 1,2,4-三唑衍生物,没有得到相应的区域异构体。